Comparing SARS-CoV-1 & -2

Video

Adam Brufsky, MD, explains the insights years of research into SARS-CoV-1 may hold for SARS-CoV-2.

Adam Brufsky, MD, explains the insights years of research into SARS-CoV-1 may hold for SARS-CoV-2.

Newsletter

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Subscribe Now!
Recent Videos
Related Content
Monoclonal Antibody Shows 84% Relative Risk Reduction of Symptomatic COVID-19 vs Placebo

Monoclonal Antibody Shows 84% Relative Risk Reduction of Symptomatic COVID-19 vs Placebo

John Parkinson
June 29th 2025
Article
A Passion for Infectious Disease Education and Communication

A Passion for Infectious Disease Education and Communication

Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; and Ryan P. McNamara, PhD;Timothy Gauthier, PharmD, BCPS, BCIDP
June 16th 2025
Podcast
The Lingering Threat: Managing Severe COVID-19 in the Postpandemic Era

The Lingering Threat: Managing Severe COVID-19 in the Postpandemic Era

James Wilson, DO;Luke Buxton, DO
June 12th 2025
Article
From Pathogen to Infectious Disease Diagnosis: Identifying a Novel Variant of Klebsiella Pneumoniae

From Pathogen to Infectious Disease Diagnosis: Identifying a Novel Variant of Klebsiella Pneumoniae

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc ;Jose Alexander, MD, ABMM, ABAIM, FCCM, CIC, ASCP, BCMAS
December 23rd 2024
Podcast
FDA Approves Moderna’s COVID-19 Vaccine

FDA Approves Moderna’s COVID-19 Vaccine

John Parkinson
May 31st 2025
Article
Antibiotic Practices For Sinusitis in Outpatient Settings Suggest Overprescribing

Antibiotic Practices For Sinusitis in Outpatient Settings Suggest Overprescribing

John Parkinson
May 29th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.